Reduction in the resident intestinal myelomonocytic cell population occurs during Apc(Min/+) mouse intestinal tumorigenesis

por Faluyi, Olusola O., Hull, Mark A., Markham, Alexander F., Bonifer, Constanze, Coletta, P. Louise
Publicado 2021

Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre

por Faluyi, Olusola O, Connor, Joanna L, Chatterjee, Madhuchanda, Ikin, Carl, Wong, Helen, Palmer, Daniel H
Publicado 2017

Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes

por Gray, Simon, Letissier, Octave, d’Abrigeon, Constance, Shah, Dinakshi, Wardell, Stephen, Faluyi, Olusola, Lamarca, Angela, Hubner, Richard A., Edeline, Julien, Valle, Juan W., McNamara, Mairéad G.
Publicado 2023

TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

por Palmer, Daniel H., Valle, Juan W., Ting Ma, Yuk, Faluyi, Olusola, Neoptolemos, John P., Jensen Gjertsen, Trine, Iversen, Berit, Amund Eriksen, Jon, Møller, Anne-Sophie, Aksnes, Anne-Kirsti, Miller, Robert, Dueland, Svein
Publicado 2020

NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/fol...

por Craig, Zoe, Swain, Jayne, Batman, Emma, Wadsley, Jonathan, Reed, Nicholas, Faluyi, Olusola, Cave, Judith, Sharma, Rohini, Chau, Ian, Wall, Lucy, Lamarca, Angela, Hubner, R, Mansoor, Wasat, Sarker, Debashis, Meyer, Tim, Cairns, David A, Howard, Helen, Valle, Juan W, McNamara, Mairéad G
Publicado 2020

Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome

por Korpanty, Grzegorz J., Eng, Lawson, Qiu, Xin, Faluyi, Olusola Olusesan, Renouf, Daniel J., Cheng, Dangxiao, Patel, Devalben, Chen, Zhuo, Tse, Brandon C., Knox, Jennifer J., Dodbiba, Lorin, Teichman, Jennifer, Azad, Abul Kalam, Wong, Rebecca, Darling, Gail, Reisman, David, Cuffe, Sinead, Liu, Geoffrey, Xu, Wei
Publicado 2017

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival

por Faluyi, Olusola O., Eng, Lawson, Qiu, Xin, Che, Jiahua, Zhang, Qihuang, Cheng, Dangxiao, Ying, Nanjiao, Tse, Alvina, Kuang, Qin, Dodbiba, Lorin, Renouf, Daniel J., Marsh, Sharon, Savas, Sevtap, Mackay, Helen J., Knox, Jennifer J., Darling, Gail E., Wong, Rebecca K. S., Xu, Wei, Azad, Abul Kalam, Liu, Geoffrey
Publicado 2017

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroen...

por McNamara, Mairéad G., Swain, Jayne, Craig, Zoe, Sharma, Rohini, Faluyi, Olusola, Wadsley, Jonathan, Morgan, Carys, Wall, Lucy R., Chau, Ian, Reed, Nick, Sarker, Debashis, Margetts, Jane, Krell, Daniel, Cave, Judith, Sothi, Sharmila, Anthoney, Alan, Bell, Christopher, Patel, Alkesh, Oughton, Jamie B., Cairns, David A., Mansoor, Wasat, Lamarca, Angela, Hubner, Richard A., Valle, Juan W.
Publicado 2023